MedCap
  • Home
  • About MedCap
    • About MedCap
    • Mission and Objectives
    • Investment Strategy
    • MedCap as an Owner
    • Board of Directors
    • Management
  • Operations
    • Operations
    • MedTech Business Area
    • Specialty Pharma Business Area
    • Acquisition History
  • Investors
    • Investors
    • MedCap as an Investment
    • The Share
      • Share Data
      • Changes in Share Capital
      • Shareholder Structure
      • Insider Trading
      • Analysts and Market Makers
      • Dividend Policy
    • Financial Information
      • Interim Reports
      • Prospectus
      • Annual Reports
      • Presentations
      • Financial Targets
      • Investor Policy
      • IR Calendar
      • IR Contacts
      • Definitions
      • Accounting Policies
      • Key Figures
    • Corporate Governance
      • Corporate Governance Report
      • Articles of Association
      • General Meeting
      • Nomination Committee
      • Board Duties
      • Committees
      • Board Remuneration
      • Internal Controls
      • Management Duties
      • Remuneration
      • Auditors
    • Calendar
  • Sustainability
  • GDPR
  • Media
    • Media
    • Press Releases
      • Regulatory Press Releases
      • None-Regulatory Press Releases
    • Request Information
  • Contact
  • Search

General meeting

The general meeting is the company’s highest decision-making body. The annual general meeting must by law be held within six months of the end of the financial year. The annual general meeting decides on issues such as adoption of the income statement and balance sheet, appropriation of the company’s profit or loss, discharge from liability, election of directors and appointment of auditors.

The notice to attend the annual general meeting or any extraordinary general meeting dealing with amendments to the articles of association will be issued not earlier than six and not later than four weeks prior to the meeting. The notice to attend any other general meeting will be issued not earlier than six and not later than three weeks prior to the meeting. Shareholders that are recorded in the shareholder register administered by Euroclear on behalf of MedCap not later than five weekdays prior to the meeting, and that have notified the company of their participation in accordance with the instructions in the notice to attend the meeting, have the right to participate in, and vote at, the annual general meeting. Shareholders may be represented by proxy.

Right to attend general meetings

Shareholders that wish to attend a general meeting must be recorded in the share register administered by Euroclear on the date that falls five weekdays prior to the meeting, and must also notify the company of their participation not later than the date specified in the notice to attend the meeting. Shareholders may attend the meeting in person or by proxy with power of attorney, and may be accompanied by a maximum of two assistants. It is usually possible for shareholders to register for a general meeting in several ways, as specified in the notice. A shareholder is entitled to vote using all shares held by the shareholder in the company.

Initiatives from shareholders

Shareholders that wish to put forward a matter for consideration by the general meeting must submit a written request to the board. Any such request must normally be received by the board not later than seven weeks prior to the meeting.

Previous general meetings

Protokoll extra bolagsstämma 2020-12-14

Bilaga 2 & 3 till protokoll extra stämma 2020-12-14

Kallelse extra bolagsstämma 20201214 (Extra General Meeting)

Reviderat förslag incitamentprogram extra stämma 14 dec 2020

MedCap förslag om LTIP

Bilaga A_Teckningsoptionsvillkor

Fullmaktsformulär

Formulär för poströstning_rev

Styrelseredogörelse_underskriven 4147-6821-5848

Revisorsyttrande_underskrivet 4132-9182-0840

AGM minutes 2019-05-13 (Swedish)

Appendix 1-6 AGM MedCap AB 13 maj 2019 (Swedish)

AGM minutes 21 May 2018 (Swedish)

Appendix 1-7 from AGM 21 May 2018 (Swedish)

EGM minutes 6 November 2017 (in Swedish)
Appendix 2 EGM minutes 6 November 2017 (in Swedish)
AGM minutes 4 September 2017 (in Swedish)
Appendix 2-5 from AGM 4 september 2017 (in Swedish)
EGM minutes 28 October 2016 (in Swedish)
AGM minutes 2 September 2016 (in Swedish)
EGM minutes January 2016 (in Swedish)
EGM minutes November 2015 (in Swedish)
AGM minutes 2015 (in Swedish)
AGM minutes 2014 (in Swedish)
AGM minutes 2013 (in Swedish)
EGM minutes 2012 (in Swedish)
AGM minutes 2012 (in Swedish)
AGM minutes 2011 (in Swedish)
AGM minutes 2010 (in Swedish)
AGM minutes 2009 (in Swedish)
AGM minutes 2008 (in Swedish)

INFORMATION ABOUT FORTHCOMING GENERAL MEETINGS

  • Investors
  • MedCap as an Investment
  • The Share
    • Share Data
    • Changes in Share Capital
    • Shareholder Structure
    • Insider Trading
    • Analysts and Market Makers
    • Dividend Policy
  • Financial Information
    • Interim Reports
    • Prospectus
    • Annual Reports
    • Presentations
    • Financial Targets
    • Investor Policy
    • IR Calendar
    • IR Contacts
    • Definitions
    • Accounting Policies
    • Key Figures
  • Corporate Governance
    • Corporate Governance Report
    • Articles of Association
    • General Meeting
    • Nomination Committee
    • Board Duties
    • Committees
    • Board Remuneration
    • Internal Controls
    • Management Duties
    • Remuneration
    • Auditors
  • Calendar
  • About MedCap
  • Mission and Objectives
  • Investment Strategy
  • MedCap as an Owner
  • Board of Directors
  • Management
  • Operations
  • MedTech Business Area
  • Specialty Pharma Business Area
  • Acquisition History
  • Investors
  • Investors
  • The Share
  • Financial Information
  • Corporate Governance
  • Calendar
  • Media
  • Press Releases
  • Request Information
  • Image Archive
  • Contact
MedCap AB | Sundbybergsvägen 1 | 171 73 Solna | +46 8 34 71 10 | info@medcap.se
Scroll to top